Anika Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Anika Therapeutics, Inc. (ANIK) reported Gain (Loss) on Disposition of Assets of $84.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-07-29
- Anika Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $32.00K, a 84.39% decline year-over-year.
- Anika Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $52.00K, a 82.67% decline year-over-year.
- Anika Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $451.00K.
- Anika Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was $205.00K.
- Anika Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2013 was $126.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $84.00K 10-Q · filed 2026-07-29 | |||
| 2026-03-31 | $52.00K 10-Q · filed 2026-04-30 | ||||
| 2025-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $656.00K derived: sum of 2 quarters · filed 2026-07-29 | $956.00K 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $505.00K 10-Q · filed 2026-07-29 | |||
| 2025-03-31 | $300.00K 10-Q · filed 2026-04-30 | ||||
| 2024-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$97.00K 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | ||||
| 2013-12-31 | -$316.34K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $126.00K 10-K · filed 2016-03-10 | $126.28K 10-K · filed 2015-03-13 | ||
| 2013-09-30 | $442.34K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |